How Ghrelin in the Brain Speeds Up Gut Movement Through a Multi-Step Signaling Chain
Injecting ghrelin into a specific brain region (PVN) dose-dependently sped up intestinal transit in rats by activating a signaling chain from central ghrelin receptors through neuropeptide Y to gut nerve acetylcholine receptors.
Quick Facts
What This Study Found
Ghrelin injected into the paraventricular nucleus (PVN) at doses of 0.03, 0.08, and 0.24 nM dose-dependently accelerated small intestinal transit (SIT) in rats. This effect was systematically dissected:
- GHSR antagonist (D-Lys3-GHRP6, 1 nM) competitively inhibited ghrelin's excitatory effect on SIT and interdigestive myoelectric complex (IMC) activity
- NPY neutralization in the PVN using anti-NPY immunoglobulin also diminished the excitatory effect on IMC
- Peripheral muscarinic acetylcholine receptor blockade with intravenous atropine reduced ghrelin's gut motility effects
- c-Fos immunohistochemistry showed ghrelin upregulated neuronal activation in the PVN, other central nuclei, and enteric nervous plexuses of the stomach, duodenum, and proximal colon — all dependent on central GHSR activation
Key Numbers
How They Did This
Thirty-six male Sprague-Dawley rats were surgically fitted with duodenal catheters and PVN cannulas. Multiple experimental groups received: ghrelin at three doses (0.03, 0.08, 0.24 nM) into the PVN; GHSR antagonist D-Lys3-GHRP6 alone or before ghrelin; anti-NPY IgG into the PVN; or intravenous atropine. Small intestinal transit was measured via the catheter system. Interdigestive myoelectric complex recordings were obtained through implanted intestinal electrodes. Neuronal activation was mapped using c-Fos immunohistochemistry in brain regions and enteric nervous system plexuses.
Why This Research Matters
Millions of people suffer from gut motility disorders like gastroparesis, irritable bowel syndrome, and post-operative ileus. Understanding the precise brain-gut signaling pathway that ghrelin uses to control intestinal movement could lead to more targeted therapies. This study maps out a complete signaling chain — from a specific brain nucleus through neuropeptide intermediaries to gut nerve endings — providing multiple potential intervention points for drug development.
The Bigger Picture
This study adds important mechanistic detail to the growing understanding of ghrelin as a master regulator of the brain-gut axis. Ghrelin agonists (like relamorelin) are already being developed for gastroparesis, while ghrelin receptor blockers are being explored for addiction and obesity. By mapping the complete signaling chain from brain to gut, this work helps explain why targeting ghrelin can have such wide-ranging effects on digestive function and informs the design of more precise gut-motility drugs.
What This Study Doesn't Tell Us
The study was conducted in anesthetized rats with surgically implanted cannulas and catheters, which is a highly artificial setting that may not reflect normal physiology. Direct PVN injection bypasses the normal routes by which ghrelin reaches the brain. Only male rats were used. The 36-rat sample was split across multiple experimental groups, resulting in small group sizes. The study examined acute effects only — chronic ghrelin exposure might produce different results due to receptor desensitization.
Questions This Raises
- ?Does circulating ghrelin from the stomach reach the PVN in sufficient concentrations to produce the same gut motility effects seen with direct injection?
- ?Could targeting the NPY signaling step specifically allow for gut motility modulation without the appetite effects of ghrelin?
- ?Do ghrelin's effects on gut motility through this pathway contribute to the gastrointestinal side effects seen with GLP-1 agonists that suppress ghrelin?
Trust & Context
- Key Stat:
- 3-step signaling chain identified Ghrelin activates brain GHSR receptors → neuropeptide Y signaling → enteric cholinergic neurons to control gut motility
- Evidence Grade:
- This is a preclinical mechanistic study in rats using invasive surgical techniques and pharmacological blockade experiments. The systematic approach of blocking each pathway component adds rigor. However, the findings are limited to an animal model under artificial conditions and have not been validated in humans.
- Study Age:
- Published in 2015, this study provides foundational mechanistic data on ghrelin's brain-gut signaling that remains relevant to ongoing development of ghrelin-based gut motility drugs.
- Original Title:
- Extrinsic ghrelin in the paraventricular nucleus increases small intestinal motility in rats by activating central growth hormone secretagogue and enteric cholinergic receptors.
- Published In:
- Peptides, 74, 43-9 (2015)
- Authors:
- Wang, Yan(6), Chen, Fenrong, Shi, Haitao, Jiang, Jiong, Li, Hong, Qin, Bin, Li, Yong
- Database ID:
- RPEP-02830
Evidence Hierarchy
Frequently Asked Questions
What is the paraventricular nucleus and why is it important for gut function?
The paraventricular nucleus (PVN) is a cluster of neurons in the hypothalamus, a brain region that controls many automatic body functions. The PVN acts as a relay station connecting hormonal signals (like ghrelin from the stomach) to the autonomic nervous system that controls gut movement. When ghrelin activates the PVN, it sends signals down to the gut's own nervous system, speeding up intestinal contractions.
Could this research lead to new treatments for digestive problems?
Potentially. By identifying three specific steps in the brain-to-gut signaling chain (ghrelin receptors, neuropeptide Y, and cholinergic gut nerves), the study provides multiple targets for drug development. For conditions like gastroparesis (slow stomach emptying), drugs that activate this pathway could speed up digestion. For conditions like diarrhea-predominant IBS, blocking specific steps might slow things down without affecting other aspects of ghrelin signaling like appetite.
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-02830APA
Wang, Yan; Chen, Fenrong; Shi, Haitao; Jiang, Jiong; Li, Hong; Qin, Bin; Li, Yong. (2015). Extrinsic ghrelin in the paraventricular nucleus increases small intestinal motility in rats by activating central growth hormone secretagogue and enteric cholinergic receptors.. Peptides, 74, 43-9. https://doi.org/10.1016/j.peptides.2015.09.009
MLA
Wang, Yan, et al. "Extrinsic ghrelin in the paraventricular nucleus increases small intestinal motility in rats by activating central growth hormone secretagogue and enteric cholinergic receptors.." Peptides, 2015. https://doi.org/10.1016/j.peptides.2015.09.009
RethinkPeptides
RethinkPeptides Research Database. "Extrinsic ghrelin in the paraventricular nucleus increases s..." RPEP-02830. Retrieved from https://rethinkpeptides.com/research/wang-2015-extrinsic-ghrelin-in-the
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.